About
Small molecule oncology medicines
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
211
By Phase
PHASE1: 2PHASE3: 1
By Status
RECRUITING: 1COMPLETED: 1SUSPENDED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06239623Lead Sponsor
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
PHASE1Recruiting
60 participants
Started: Apr 2, 2022 · Completed: Dec 30, 2024
NCT06840158Lead Sponsor
Double-blind Comparative Randomized Multicenter
PHASE3Completed
80 participants
Started: Oct 15, 2021 · Completed: Jun 29, 2022
NCT04418167Lead Sponsor
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
PHASE1Suspended
71 participants
Started: Jun 18, 2020 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...